CST3 Polyclonal Antibody

Elabscience
Product Code: E-AB-12265
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-12265-20uL20uL£125.00
Quantity:
E-AB-12265-60uL60uL£172.00
Quantity:
E-AB-12265-120uL120uL£237.00
Quantity:
E-AB-12265-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
Ice packs
Storage:
-20°C

Images

1 / 2
Western Blot analysis of Human fetal brain tissue using CST3 Polyclonal Antibody at dilution of 1:2400
2 / 2
Immunohistochemistry of paraffin-embedded Human gastic cancer using CST3 Polyclonal Antibody at dilution of 1:50

Western Blot analysis of Human fetal brain tissue using CST3 Polyclonal Antibody at dilution of 1:2400
Immunohistochemistry of paraffin-embedded Human gastic cancer using CST3 Polyclonal Antibody at dilution of 1:50

Documents

Further Information

Abbreviation:
CST3
Background:
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located in the cystatin locus and encodes the most abundant extracellular inhibitor of cysteine proteases, which is found in high concentrations in biological fluids and is expressed in virtually all organs of the body. A mutation in this gene has been associated with amyloid angiopathy. Expression of this protein in vascular wall smooth muscle cells is severely reduced in both atherosclerotic and aneurysmal aortic lesions, establishing its role in vascular disease.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Calculated MW:
16kDa
Concentration:
0.5 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:1000-1:5000, IHC 1:50-1:200
Immunogen:
Synthetic peptide of human CST3
Purification method:
Affinity purification
Target Synonym:
AD 8;AD8;Amyloid angiopathy and cerebral hemorrhage;ARMD11;bA218C14.4 (cystatin C);bA218C14.4;Cst 3;Cst3;CST3 protein;Cystatin 3;Cystatin-3;Cystatin-C;Cystatin3;CystatinC;CYTC;Epididymis secretory protein Li 2;Gamma trace;Gamma-trace;HCCAA;HEL S 2;MGC117328;Neuroendocrine basic polypeptide;Post gamma globulin;Post-gamma-globulin
UNIProt ID:
P01034